IDEXX Laboratories (IDXX) news
Recent news
IDEXX Laboratories, Inc.: KeyBanc initiates coverage with sector weight rating
KeyBanc Capital Markets has initiated coverage on IDEXX Laboratories, Inc. (NASDAQ: IDXX) with a sector weight rating, signaling a neutral stance relative to the broader market. The move comes amid ongoing analyst activity surrounding the stock, which has seen mixed price target adjustments in…
AInvest Wire · 2d agoChicago Pacific founders pet fund announces exit of Covetai following acquisition by Idexx Laboratories
AInvest Wire · Sep 30, 2026IDEXX Laboratories: Financial terms of Covetai acquisition not disclosed
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software solutions, has completed the acquisition of Covetai, a provider of digital health solutions for veterinary practices. The financial terms of the transaction were not disclosed by either party [1]. The…
AInvest Wire · Sep 16, 2026IDEXX Laboratories acquires Covetai to advance veterinary workflow intelligence
AInvest Wire · Sep 16, 2026Barclays cuts target price to $710 from $800 for Idexx Laboratories, Inc.
Barclays has revised its price target for IDEXX Laboratories, Inc. (IDXX) to $710 from $800, reflecting a more cautious outlook on the stock's near-term performance. The adjustment was made following a reassessment of the company's growth trajectory and market conditions, though the firm has not…
AInvest Wire · Aug 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.